Effect of Spray-Drying and Electrospraying as Drying Techniques on Lysozyme Characterisation by Abraham, Ijeoma et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Effect of Spray-Drying and 
Electrospraying as Drying 
Techniques on Lysozyme 
Characterisation
Ijeoma Abraham, Eman Ali Elkordy, Rita Haj Ahmad, 
Zeeshan Ahmad and Amal Ali Elkordy
Abstract
The production of biopharmaceutical formulation incorporates several 
difficulties embracing their physical and chemical instabilities. In this study, 
two drying techniques, namely, spray-drying and electrospraying, were used to 
assess their application on lysozyme (as a model protein) without and with the 
use of betacyclodextrin. Samples were prepared in the ratio of 1:1 w/w (protein/
betacyclodextrin), and several characterisation methods were applied to study 
the percentage (%) yield, morphology of the produced partials, thermal stability 
and biological activity of the protein. The results show the two drying methods 
led to different particle morphology as spherical-like shape was produced by 
spray-drying, while rodlike shape was generated by electrospraying with larger 
particle size. Lysozyme formulations produced by electrospraying were stable 
just directly after preparation, but after few weeks, those formulations showed 
visible aggregates. The biological activity of lysozyme was preserved by both 
drying techniques. In conclusion, both drying methods have different effects on 
the protein integrity and biological activity in which spray-drying shows more 
promising results.
Keywords: lysozyme, spray-drying, electrospraying, thermal stability,  
biological activity
1. Introduction
The majority of the FDA-approved protein-based medicines are delivered via 
conventional injection route (e.g. subcutaneous, intramuscular or intravenous). 
The pharmaceutical industries are faced with one of the most significant problems 
in protein manufacturing. One of the setbacks is the stability in the processing, 
manufacturing and storage of these therapeutic drugs. Solid dosage forms of 
therapeutic proteins could improve protein’s bioavailability and stability during 
processing and storage. Various formulation techniques were applied utilising 
drying process aiming to develop a stable protein formulation (e.g. spray-drying, 
freeze drying, electrospraying, electrospinning, etc.). This chapter will be looking 
at the stability of lysozyme as a model of protein using spray-drying technique and 
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electrohydrodynamic atomisation (EHDA) also known as electrospray. Very few 
publications have looked at the stability of lysozyme using EHDA technique. This 
challenge has necessitated the contribution towards this area.
1.1 Proteins
Proteins are macromolecules which require their native structure to be bio-
logically active, and their conformation is very important in the development of 
protein drugs. They may denature with structural changes under stress, and there 
will be a loss of activities in the molecules. Examples of stresses are heat, elevated 
temperature, pressure, surface adsorption and pH [1]. Proteins undergo physical 
and chemical degradation; examples of physical degradation include aggregation, 
precipitation and unfolding as updated in Hui et al. [2] which involves the transi-
tion of protein from its native state to an unfolded state and will follow a significant 
loss in the function of a protein which generally will cause an unstable solution 
during the processing, manufacturing and storage.
1.2 Structure of proteins
Proteins consist of chains or small units of amino acid also known as amino 
acid polymers or building blocks [3] which contain the backbone or main chain of 
repeated units with attachments of variable side chains and are linked by peptide 
bonds. Each protein has a unique sequence of the side chains which determines 
the characteristics of the individual chain. There is a free carboxyl terminal at the 
end and a free amino terminal at the other end of every protein except for few 
cyclic polypeptides. The amino acid sequence is given in order of N-terminal to the 
C-terminal [4].
They are macromolecules heterogeneous in their native environment and are in 
most cases unstable. The ordering sequences in amino acids are referred to as the 
primary structure of protein and the secondary structure (α helix and β sheet); 
these are three-dimensional elements which all have an orientation of the protein 
backbone; tertiary structure is formed from secondary structural elements [5]; and 
quaternary structure comprises of several subunits with tertiary structures [6]. The 
configuration is determined by the native form followed by the assignment of α 
helix and β sheet which produces secondary conformation as these molecules are all 
linked by hydrogen bond [7].
This stability of the protein structure should include the three-dimensional state, 
the folded and the tertiary state which are all required for the biological activity. 
Although conformational stability is not enough rather, the protein must be able to 
find the folding pathway or its state within a short time from a denatured, unfolded 
conformation [8]. Folding maximises exposure of polar groups to the solvent and 
minimises exposure of non-polar groups. Protein unfolding is the transition from a 
native form to a denatured state [9]. When molecules are in aqueous solution, there is 
an equilibrium between folded which is the native state conformation and unfolded 
known as denatured. Native conformation stability is based on the relationship 
thermodynamically between ΔS and ΔH and the extent of ΔG-Gibbs free energy 
of the system. When the magnitude of ΔG is negative, it shows that there is a high 
stability of the native conformation than the denatured state which means that the 
greater the stability, the more negative is the ΔG. During protein unfolding, the main 
critical bonds required for protein stabilization are broken. Unfolding of proteins can 
take place at high temperatures, where the entropy is the main factor and the confor-
mational entropy overpowers stabilizing forces. Hence, protein unfolding takes place. 
DSC takes measurement of ΔH of unfolding as a result of heat denaturation [10, 11].
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1.3 Stability of proteins
Stability of protein is the achievement of a balance between stabilising and 
destabilising forces. The stabilising forces are caused by protein-solvent and intra-
protein interaction, while the other is caused by substantial increase in entropy of 
unfolding [12].
One of the major challenges with the biopharmaceuticals is achieving protein 
stability.




Conformational stability describes the ability of the protein to maintain its 
native structure and be properly folded. Chemical stability is the stability among 
amino acid, covalent bond and different protein domains, while colloidal stability 
is the ability of the native structure of protein in a solution to avoid precipitation, 
aggregation and phase separation. However, it is necessary to maintain all types of 
stability during all the stages of development, processing and manufacturing.
The instability of protein necessitates the production in solid forms as solid 
proteins can be crystallised and dried [13] and its administration as a drug injection 
rather than through oral means like other drugs. Therefore, excipients also known 
as stabilisers are introduced to preserve the state and folding reversibility of pro-
teins and reduce aggregation [14]. In effect to tackle protein degradation, necessary 
precautions and measures are taken to select the appropriate formulations for any 
excipients as well as the right technique for optimisation.
Proteins produced in different forms, like liquid formulations for medicines, are 
injectable due to the ease of preparation and are the most preferred, in manufac-
turing as well as the end users [15]. Unfortunately, it is not convenient due to the 
susceptibility of these proteins to the risk factors. This has instigated the consider-
ation of the use of excipients as earlier mentioned in a dry solid state as important. 
Glass-forming agents such as saccharides, polyols and organic acids have been 
studied extensively over the years to stabilise spray-dried proteins in the solid state 
[16, 17]; these excipients stabilise the macromolecules by two primary mechanisms. 
Usually, the glass-forming ability of these excipients preserves the structure of 
proteins by trapping it in a rigid amorphous glass matrix [18, 19].
1.4 Lysozyme as a protein model
Lysozyme (1,4-β-N-acetylmuramidase) is the model of protein used in this study 
because lysozyme is one of the most potent proteins containing about 129 amino 
acids and has a high ionic strength. pH and the enzymes depend highly on their 
tertiary structure for maintaining their biological activity [20]. Lysozyme is folded 
into globular compact structure with a long cleft in the surface of the protein. The 
binding of the bacterial carbohydrate chain and the cleaving take place in the active 
site known as the cleft [21]; it has a molecular weight of 14.3 kDa and an isoelectric 
point of 10.7.
Lysozyme can be protected against bacteria through its activity as an enzyme 
as the role of an enzyme is to speed up the rate of chemical reaction in the body. 
Usually, polysaccharides are found in the cell walls of the affected bacteria which 
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contain amine groups (NH2) with sugar and side chains of sugar. Addition of water 
molecules to the sugar linkage causes lysozyme to degrade the polysaccharide, 
thereby causing it to break open. Its activity is a function of the ionic strength and 
pH. It is active between a pH of 6.0 and pH 9.0. Maximum activity is observed at a 
pH of 6.2 and ionic strength 0.02–0.100 M compared to 0.01–0.06 M at pH 9.2.
1.5 Drying techniques
1.5.1 Electrohydrodynamic atomisation
EHDA also known as electrospray is a drying technique used in the production of 
dry powder with the help of charges. It was first observed and recorded by Williams 
Gilbert in 1600 [22]. It is a process where a liquid imposes through a nozzle (which 
is connected to a voltage supply) at a certain flow rate, subjecting to high potential 
electric field. As a result, the meniscus is elongated to form a jet that breaks up 
into droplet under electrical force influence. Particles can then be collected at a 
collecting platform that is located ~20 cm under the spraying nozzle (Figure 1). 
Various spraying modes can be obtained depending on the strength of the electric 
stress and on the kinetic energy of the liquid leaving the nozzle for nanoparticle 
production. It is a well-practised technique for generating very fine droplets with 
monodispersed size from the liquid under the influence of electric forces [23]. It can 
achieve controlled monodispersity and morphology of particles without denatur-
ation of bioactive molecules throughout the process, and this is possible with the use 
of emulsion. However, it has the potential to reduce or stop degradation of protein 
drugs and offer a strict control over particle morphology and size distribution. The 
principle of electrospray is based on the theory of charged droplets, ‘stating that an 
electric field applied to a liquid droplet exiting a capillary is able to deform the inter-
face of the droplet’ [24]. Some literatures published state that electrospray is better 
than the other drying techniques because of its advantages as it does not require a 
high temperature, might use little or no emulsion also and may not need further 
drying. In a study [25], lysozyme as a model protein was encapsulated within 
biodegradable microparticles using coaxial electrospray and the authors concluded 
that electrospray could be a promising approach to encapsulate biomolecules [25]. 
Bock et al. have also done a review on electrospraying of polymer with therapeutic 
Figure 1. 
Picture shows electrospray technique.
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molecules as a state of the art and have concluded also that electrospraying tech-
nique may emerge as promising in the production of particles with entrapped 
therapeutic molecules that may be released as particle degradation occurs. So far, 
most of the research reports for electrospraying technique using proteins were 
based on using polymeric systems in order to encapsulate the protein either in 
protein carriers or nano- or microcapsules. For example, Suksamran et al. [26] 
successfully synthesised alginate microparticles (0.9–4 μm in diameter) with ~50% 
entrapment efficiency of bovine serum albumin that raised promises for oral drug 
delivery of proteins. Moreover, tristearin nanoparticles (∼100–300 nm in diam-
eter) were developed to aid the delivery of angiotensin II alongside clear core-shell 
particles with ∼92 ± 1.8% encapsulation efficiency [27]. Electrosprayed core-shell 
microspheres (2–8 μm) with encapsulated bovine serum albumin as the core and an 
amphiphilic biodegradable polymer (poly(ε-caprolactone)-poly(aminoethyl eth-
ylene phosphate) block copolymer) as the shell for protein delivery were generated 
by a single-step electrospraying. The protein release profiles of the microspheres 
exhibited steady release kinetics for a period of 3 weeks without a significant initial 
burst [28].
1.5.2 Spray-drying
Spray-drying is an established technology for the production of dried products 
from the liquid state. This method has gained increased interest in dry power for-
mulation over the past decade, due to its potential simplicity, adaptability, scalability 
and cost-effectiveness [29, 30]. It is a method that has been studied in dry powder 
protein production involving the use of high temperature during the drying process. 
The principle of spray-drying method relies on atomisation of a drug solution that is 
pumped into a dry hot chamber in the form of droplets. By the influence of the heat, 
these droplets evaporate leading to dry solids in either powder, granules or agglom-
erated particles based on the chemical and physical properties of the feed in addition 
to the design of the used spray-dryer (Figure 2). One of the challenges of producing 
protein formulation utilising spray-drying method is the ability to destabilise the 
protein due to hot temperature and pressure during the production process com-
pared to electrospray which uses charges for drying.
Figure 2. 
Picture shows the spray-drying technique.
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Various reports documented the use of spray-drying that produced protein 
formulations with high protein activity. For instance, the fabrication of uniform 
trehalose microparticles immobilised with trypsin showed ~97.7 ± 2.6% biological 
activity using an optimal trypsin/trehalose mass ratio of 1:1 [31]. Insulin mic-
roparticles were also designed by spray-drying method to bypass deposition in the 
extrathoracic region (mouth-throat). The total lung dose of >95% was achieved 
indicating a high degree of lung targeting [32]. Newly developed microencapsulated 
solid lipid nanoparticles containing papain (as a model protein) were prepared by 
spray-drying method. Papain was adsorbed onto glyceryl dibehenate and glyceryl 
tristearate solid lipid nanoparticle. The protein was found to be released from the 
particles to a large extent. Moreover, protein stability was reserved throughout 
spray-dried microsphere production [33].
This chapter aims to describe the effect of spray-dried and electrospray-dried 
formulations on lysozyme with and without excipients using various characterisa-
tion techniques like differential scanning calorimetry (DSC) to determine the 
thermal stability with lysozyme solid samples, UV-Vis spectroscopy for the enzy-
matic activity, dynamic light scattering for particle size, scanning electron micro-
scope (SEM) for morphology of the particles and high-sensitivity DSC for thermal 
stability using lysozyme solutions and two drying (electrospray and spray-drying) 
techniques, to dry powders for characterisation.
2. Materials and methods
2.1 Materials
Chicken egg white lysozyme in lyophilised powder (90%), ethanol, Micrococcus 
lysodeikticus and betacyclodextrin were purchased from Sigma-Aldrich Chemicals 
Company. Sodium phosphate monobasic anhydrous, disodium hydrogen ortho-
phosphate anhydrous and sodium chloride were obtained from Fisher Scientific 
Company.
2.2 Methods
2.2.1 Preparation of spray-dried protein
Aqueous lysozyme solutions (1% w/v) were spray-dried without and with an 
excipient (betacyclodextrin) via a BÜCHI Mini Spray Dryer B-290. Excipients were 
used at the concentrations of 1% w/v. The protein solution run through a silicone 
tubing of inner diameter of 4 mm, peristaltic feed pump (35%) to an 0.5 mm diam-
eter atomising nozzle at rate of 20 ml/min and compressed air at rate of 600 l/h. In a 
glass chamber, protein solutions were sprayed at an inlet temperature of 130 ± 3°C, 
and outlet temperature was 73 ± 4°C. To minimise the effect of heat stress on the 
protein, a cooling water was distributed through a jacket around the nozzle. Spray-
dried protein powder were collected by a high-performance cyclone separator and 
stored in glass vials at 3–4°C.
2.2.2 Preparation of electrosprayed lysozyme
Lysozyme solutions (1% w/v) were prepared using (80/20 v/v) ethanol/water. 
Electrosprayed formulations were prepared without and with excipients (1% w/w 
of betacyclodextrin). A syringe containing 5 ml of the protein solution was attached 
to a syringe infusion pump (Harvard Apparatus, Pump 11 Elite, USA) attached 
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to a high-power voltage supply (Glassman High Voltage Supply, UK). The protein 
solution was run through a silicone tubing attached to a stainless steel needle (inner 
diameter 0.3 cm) at a flow rates of 15 μL/min. Atomised particles were collected 
on microscope slides which fitted 20 cm below the tip of the nozzle. A high voltage 
was used to maintain the voltage range of 9–18 kV. The electrospraying process was 
conducted at ambient temperature (23°C).
2.2.3 Characterisation of spray-dried and electrosprayed lysozyme
2.2.3.1 Scanning electron microscopy
Microscopic examination of spray-dried and electrosprayed formulations was 
investigated utilising scanning electron microscope (SEM) (Hitachi S3000-N 
variable pressure scanning electron microscope, Japan). Around 2–3 mg of dried 
lysozyme formulations were applied to a double-sided carbon tape (Agar Scientific, 
Stansted, UK), fixed on an aluminium stub. The dried powder was sputter coated 
with a mixture of gold/palladium using a Quorum Technology (Polaron Range) 
SC760 by subjecting powder to an argon atmosphere at about 10−1 mbar.
2.2.3.2 Differential scanning calorimetry (DSC)
The thermal stability of lysozyme, before and after processing, was evaluated in 
the solid form using DSC Q1000M TA instrument, England. Pure indium standard 
was utilised to calibrate the DSC instrument. Unprocessed, spray-dried and elec-
trosprayed formulation (2–3 mg) was sealed in a DSC aluminium pan with lids and 
loaded under nitrogen at a flow rate of 50 ml/min. An empty sealed pan was used as 
a reference. Pans were scanned in the range of 0–300°C at a rate of 10.0°C/min.
2.2.3.3 High-sensitivity differential scanning calorimetry (HSDSC)
High-sensitivity DSC also known as VP-DSC was used in this study to determine 
the thermal behaviour and folding reversibility of lysozyme. The fresh sample 5 mg 
of each formulation (1 ml 0.1 M phosphate buffer at a pH of 6.24) and reference 
(0.1 M sodium phosphate buffer at a PH of 6.24) was degassed and injected into the 
cells using a syringe. The sample and reference were complete for maintenance of 
equal volumes, and the same amount of lysozyme was used in each run. The sample 
and reference were heated between 20 and 90°C at 1°C/min under pressure. The 
folding reversibility each, of the denatured protein, was evaluated by cycling tem-
perature by carrying out three scans (up scan, 20–90°C; down scan, 90–20°C; and 
another up scan, 20–90°C). These engaged two or more scans at different tempera-
tures. Furthermore, before the measurement of each sample, a baseline was run by 
loading both cells (sample and reference cells) with the reference; the baseline was 
later subtracted from the protein thermal data using the MicroCal VP-DSC, USA. The 
sample was analysed with Origin DSC analysis software by normalising the concen-
tration and excesses in heat capacity. The calorimetric enthalpy changes which is the 
area under the peak (ΔH) and midpoint of the transition peak (Tm) were calculated.
2.2.3.4 Biological activity analysis of lysozyme
Utilising M501 Single Beam Scanning UV/Visible Spectrophotometer Camspec 
(Biochrom, UK), the enzymatic activity of lysozyme was investigated by determin-
ing the hydrolysis rate of β-1,4-glycosidic linkages between N-acetylglucosamine 
and N-acetylmuramic acid in bacterial cell walls. Following a procedure described 
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by Haj Ahmad et al. [34], the activity of lysozyme was assessed. A 100 ml of 
Micrococcus lysodeikticus suspension was prepared by adding 20 mg of the bacteria 
added to 10 ml of 1% sodium chloride solution and 90 ml of potassium phosphate 
buffer 0.067 M, pH 6.6. The biological reaction of lysozyme was initiated by adding 
0.5 ml of protein solution (1.5 μg/ml), prepared using the same buffer, to 5 ml of the 
bacterial suspension. The unit activity of the protein was monitored by measuring 
the reduction rate in the absorbance at 450 nm. The biological activity of lysozyme 
was assessed using the equation suggested by Shugar [35]:
  Activity  (units / mg) = ∆ 450 nm/min / 0.001 × mg enzyme present in the mixture.  (1)
2.2.3.5 Particle size distribution analysis
The particle size distribution of the dried particles was determined by dynamic 
light scattering technique using the Malvern Zetasizer (Nano ZSP, Malvern 
Instruments, UK). The particles were dispersed in ethanol containing 0.1% Tween® 
80, which was selected to achieve suitable deagglomeration. The average particle 
size was measured at a scattering angle of 90° in three replicates for each sample.
3. Results and discussion
3.1  Determination of percentage yields for spray-dried and electrosprayed 
lysozyme
Table 1 shows the percentage yield of the spray-dried and electrosprayed lysozyme 
formulation collected. For spray-dried lysozyme, 29% of the preparation was achieved. 
The percentage yield was higher (~53%) for spray-dried lysozyme with betacyclodex-
trin compared to the spray-dried lysozyme in the absence of excipient. The addition 
of betacyclodextrin reduced the deposition of spray-dried lysozyme on the wall of the 
spray-drying chamber and cyclone separator. With no significant differences, lyso-
zyme formulation produced with electrospraying produced ~30%. However, a major 
reduction was noticed for electrospraying lysozyme with betacyclodextrin (~25%). 
Around 30–40% of product yield is typically expected for spray-drying formula-
tions utilising benchtop spraying system [36]. Increasing the percentage yield can be 
achieved by introducing polymeric excipients with high glass transition temperature in 
addition to optimise the drying condition used during the spray-drying [37]. A large-
scale production is feasible in pharmaceutical industries for spray-drying formulations 
by using a large scalable spray-drier that would generate the highest possible yield 
[38]. This is also feasible for electrospraying by using, for example, a multi-tip emitter 
to improve the potential upscale electrospraying [39]. For electrospraying technique, 
the process parameters, such as feeding flow rate, voltage supply and the distance 
between the tip of the nozzle and the collecting platform, would affect the physical 
properties of the produced particles. It’s worth mentioning that the time consumed by 
each process to generate the quantity outlined in Table 1 was significantly different. 
Spray-drying process required 15–20 min for the whole sample, while more than 6 h 
was consumed to finish with all of the electrosprayed sample.
3.2  Microscopic examination of spray-dried and electrosprayed protein 
particles
Figure 3 and Table 1 show the SEM images and particle size of spray-dried 
and electrosprayed formulations, respectively. The process of protein preparation 
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had a significant impact on the morphology and size of the spray-dried and elec-
trosprayed lysozyme particles. As a result, it will impact the choice of the protein 
delivery system and route of drug administration. Protein particles produced by 
spray-drying technique were smooth and spherical in shape (Figure 3A) with a size 
of 2.3 + 0.06 μm, while mainly rodlike shape particles with few spherical particles 
were produced via electrospraying process (1.6 ± 0.19 μm). The inclusion of 
betacyclodextrin had no significant effect on the shape of electrosprayed particles 
(3.0 ± 0.91 μm), while solid dimple spheres were observed for spray-dried lysozyme 
with betacyclodextrin formulation (2.7 ± 0.5 μm) (Figure 3). For spray-drying 
process, Prinn et al. [40] suggested four categories to classify the morphology of the 
spray-dried particles: (I) smooth spheres, (II) dimpled or collapsed particles, (III) 
raisin like particles and (IV) highly crumpled folded particles. Accordingly, spray-
dried lysozyme without betacyclodextrin would fall into class I, and spray-dried 
lysozyme with betacyclodextrin would fall into class II. The rate of drying has a 
crucial impact on the morphology of the spray-dried particles; faster drying would 
result in more dimpled particles [41]. However, the spherical shape of the particles 
will not guaranty a 100% biological activity as will be discussed below. Moreover, it 
has been recognised that the optimal aerodynamic particle size distribution of par-
ticles intended for pulmonary delivery should be within the range of 1–5 μm [42]. 
Accordingly, all particles produced in this research would fit within this range and 
thus are suitable for pulmonary delivery.
The electrospraying configuration used in this study consists of one conduct-
ing needle, and one voltage was applied. A stable Taylor cone usually forms at 
the tip of the needle generating nearly uniform particles with distinct morphol-
ogy. The incorporated protein disperses equally with the solution (without and 
with the excipient) improving the amorphous nature and bioavailability (Mehta 
et al. [22]). Flow rate is highly related to the particle size of the electrosprayed 
particles. It documented that larger flow rates tend to generate smaller particle 
size [43]. The flow rate used in this study considered as low flow rate that might 
explain the large particle size of electrosprayed lysozyme especially with beta-
cyclodextrin (Table 1, Figure 3). Also, a study conducted by Gomez et al. [44], 






Tm (°C)a Apparent 
Tm (°C)b
Mean diameter 
(μm) (mean ± SD)
Unprocessed 
lysozyme
100 74.32 ± 0.16 199.06 1.4 ± 0.04
SD lysozyme 29 90.1 72.46 ± 0.38 201.30 2.3+ 0.06
ESR lysozyme 30 113 74.44 ± 0.22 222.18 1.6 ± 0.19
SD (1:1 w/w) 
lysozyme with 
betacyclodextrin




ESR (1:1 w/w) 
lysozyme with 
betacyclodextrin
25 100 74.51 ± 0.52 223.26 3.0 ± 0.91
aFor aqueous protein formulations.
bFor solid protein formulations.
SD, spray-dried; ESR, electrosprayed
Table 1. 
Shows percentage (%) yield, biological activity, denaturation temperature, Tm and particle size of dried 
lysozyme particles.
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solvent or the flow rate in order to achieve a smaller particle size. A future study 
with various lysozyme concentrations and higher and lower flow rates will be 
conducted. The particle morphology of protein formulations and size play a 
crucial role in the aerodynamic properties and performance of aerosol applica-
tions. Smooth spherical particles are more preferred than other particle shapes 
as they might result in much lower aerodynamic particle diameter in comparison 
with dense particles.
3.3 Differential scanning calorimetry (DSC)
DSC determines the variation in heat flow between the protein sample and an 
empty sealed pan that was used as a reference cell. Throughout a thermal event 
in the protein preparation, the operation of the system will conduct heat to, or 
from, the protein sample pan to maintain an equal temperature in both sample and 
reference pans. Thermal profiles of unprocessed, spray-dried and electrosprayed 
lysozyme formulations without excipients are presented in Figure 4. This repre-
sents the heat flow as a function of temperature and illustrates the apparent dena-
turation temperature Tm values of all protein preparations (Table 1). In the DSC 
thermogram scans, two endothermic peaks can be observed. The first endothermic 
broad peak (~120°C) indicates that the preparations contain some amount of water 
[45, 46]. The second endothermic peak around ~199°C represents the apparent 
denaturation transition of the protein in which the peak maximum was considered 
the apparent denaturation temperature [21].
Figure 3. 
SEM images for (A) spray-dried lysozyme, (B) spray-dried lysozyme with betacyclodextrin, (C) electrosprayed 
lysozyme and (D) electrosprayed lysozyme with betacyclodextrin.
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Spray-drying of lysozyme has improved the denaturation temperature of lyso-
zyme by about 2°C as compared with unprocessed lysozyme (Table 1). However, 
this transition was not significant. The presence of betacyclodextrin within spray-
dried sample indicated an amorphous protein content as no peak was detected 
around 199°C; this was in contrast with other publications which showed transition 
for spray-dried lysozyme with betacyclodextrin. Around 22°C increase of the dena-
turation temperature of lysozyme was observed for electrosprayed protein without 
any excipient (Table 1, Figure 4). Moreover, electrospraying of lysozyme with 
betacyclodextrin led to an increase (by ~23°C) of the apparent protein denaturation 
temperature compared to the unprocessed lysozyme. The results for electrospraying 
formulations suggest an increase of lysozyme thermal stability as they exhibited 
increase in denaturation temperatures indicating the effect of the process and the 
excipient on the protein’s integrity, and this is in consistent with the biological 
activity results for freshly dried protein samples.
HSDSC offers information about protein folding and stability by measuring 
the thermodynamic parameters in solution forms which have an impact on protein 
folding-unfolding transitions [47]. Subsequently, this method was used to assess the 
thermal stability of the prepared protein solutions after processing. Table 1 displays 
the HSDSC results for denaturation temperature of unprocessed, spray-dried and 
electrosprayed lysozyme preparations. The results (Table 1) show that the transition 
temperature (Tm) of the spray-dried formulation in the absence of betacyclodextrin 
reveals lower thermal stability (Tm was ~72°C) than the unprocessed lysozyme and 
other formulations (Tm was ~74°C). Electrosprayed samples have maintained the 
thermal stability of the protein after processing (Tm was ~74°C). However, after 
6 months of storage of electrosprayed samples in solid forms, it was noticed that 
those samples showed visible aggregates upon addition of aqueous solutions, while 
spray-dried lysozyme samples were soluble in the aqueous solutions.
3.4 Biological activity of lysozyme
The most crucial parameter in any protein formulation is to maintain the 
biological activity of the protein. This will give an indication about the integrity, 
foldability and stability of the protein. Biological activity test was run for lysozyme 
Figure 4. 
DSC thermograms for unprocessed, spray-dried and electrosprayed lysozyme.
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before and after processing. Solid protein samples were reconstituted, and the bio-
logical activity was expressed as a percentage that is relative to the control protein 
(activity of unprocessed protein was 100%). Table 1 displays the biological activity 
results for spray-dried and electrosprayed lysozyme formulations. Spray-drying 
of lysozyme without and with betacyclodextrin led to about 10% reduction of 
lysozyme activity as compared with the unprocessed lysozyme. On the other hand, 
electrospraying of lysozyme better maintained protein biological activity compared 
to spray-dried protein formulations (Table 1). However, aggregate formation in 
solutions was noticed after 6 months of storage of electrosprayed lysozyme solid 
samples, meaning that proper storage conditions require to be maintained for long-
term stability of dried lysozyme samples prepared by electrospraying technique.
The outcomes of this study could be explained on the basis that spray-drying 
process has perturbed the tertiary structure of lysozyme, thus reducing the biologi-
cal activity of the protein; these results are in agreement with Haj Ahmad et al. [21] 
and Hulse et al. [45]. Lu et al. [48] reported that the type and percentage of the 
excipient used would influence the stability of protein formulation. The addition of 
betacyclodextrin to the spray-drying formulation did not have any improvement as 
~87% biological activity of lysozyme was achieved. Sustaining the tertiary structure 
of lysozyme is critical for its full activity. One of the vital factors for this is the level 
of hydration at the active site cleft of the protein. Nagendra et al. [49] suggested 
that the active site in the lysozyme is heavily hydrated and ~0.2 grammes of water/g 
protein is required for the protein to maintain its biological activity with at least 9.4% 
of moisture content. Otherwise, the active site cleft will shrink, and thus the protein 
will inactivate [49]. On the other hand, 100% of the protein biological activity was 
observed for freshly electrosprayed lysozyme without and with betacyclodextrin 
suggesting the full hydration of the active site cleft in the protein. A study conducted 
by Gomez et al. [44] using insulin as a model protein reported electrospraying tech-
nique was gentle not to hinder the biological activity of insulin. The overall results 
suggest that different ways of drying (e.g. heating like in spray-drying and electric 
charge like in electrospraying) have different influences on the protein biological 
activity. The structure of proteins embraces several weak interactions (hydrogen 
bonging and electrostatic). These interactions can easily be affected by subjecting to 
physical and chemical stimuli that would include various processing conditions of 
conventional processing techniques (e.g. spray-drying) where high temperature or 
stress is applied. High temperature tends to denature sensitive biomolecules, such as 
proteins. Atomisation of materials by electrospraying relies mainly on evaporation of 
the solvent to generate dry particles without affecting the characteristics of proteins 
such as biological activity. While denaturation by the effect of temperature can be 
avoided, some denaturation and degradation might be initiated by the shear stress 
in the nozzle tip through which the aqueous solvent is infused [22, 37, 50, 51]. In this 
study, the biological activity of freshly dried lysozyme forms was conserved by using 
electrospraying method compared with spray-drying technique. However, aggregate 
formation in solutions was noticed after 6 months of storage of electrosprayed 
lysozyme solid samples, meaning that proper storage conditions require to be main-
tained for long-term stability of dried lysozyme samples prepared by electrospraying 
technique. Accordingly, there is a need for further study of the stability of the protein 
particles at various temperature and humidity conditions.
4. Conclusion
It was observed that electrospray lysozyme formulations without and with 
the used excipient looked promising compared to unprocessed and spray-dried 
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formulations. However, it was observed that proper storage for electrosprayed 
samples is needed as the protein degraded after some time of storage. Spray-dry 
and electrospray seem to have some positive and negative effects on the lysozyme 
depending on the technique and its used parameters.
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